Bionano Genomics (BNGO) Receivables - Net (2017 - 2025)
Historic Receivables - Net for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $4.5 million.
- Bionano Genomics' Receivables - Net fell 1800.72% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 1800.72%. This contributed to the annual value of $4.9 million for FY2024, which is 4991.84% down from last year.
- Bionano Genomics' Receivables - Net amounted to $4.5 million in Q3 2025, which was down 1800.72% from $3.6 million recorded in Q2 2025.
- In the past 5 years, Bionano Genomics' Receivables - Net registered a high of $9.8 million during Q4 2023, and its lowest value of $3.5 million during Q1 2025.
- Over the past 5 years, Bionano Genomics' median Receivables - Net value was $5.5 million (recorded in 2024), while the average stood at $6.0 million.
- In the last 5 years, Bionano Genomics' Receivables - Net surged by 7780.18% in 2021 and then crashed by 6039.35% in 2025.
- Bionano Genomics' Receivables - Net (Quarter) stood at $4.9 million in 2021, then surged by 42.32% to $7.0 million in 2022, then skyrocketed by 39.59% to $9.8 million in 2023, then plummeted by 49.92% to $4.9 million in 2024, then fell by 7.8% to $4.5 million in 2025.
- Its Receivables - Net stands at $4.5 million for Q3 2025, versus $3.6 million for Q2 2025 and $3.5 million for Q1 2025.